NSAID Sulindac and Its Analog Bind RXRα and Inhibit RXRα-Dependent AKT Signaling

Cancer Cell

Volumn 17, Issue 6, 2010, Pages 560-573

  Zhou, Hu ^a,b   Liu, Wen ^b   Su, Ying ^b   Wei, Zhen ^a   Liu, Jie ^a,b   Kolluri, Siva Kumar ^c   Wu, Hua ^a   Cao, Yu ^b   Chen, Jiebo ^b   Wu, Yin ^b   Yan, Tingdong ^a   Cao, Xihua ^b   Gao, Weiwei ^a   Molotkov, Andrei ^b   Jiang, Fuquan ^a   Li, Wen Gang ^d   Lin, Bingzhen ^b   Zhang, Hai Ping ^d   Yu, Jinghua ^b   Luo, Shi Peng ^a   Zeng, Jin Zhang ^a   Duester, Gregg ^b   Huang, Pei Qiang ^a   Zhang, Xiao Kun ^a,b   more..

^a XIAMEN UNIVERSITY   (China)

^b BURNHAM INSTITUTE   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d Xiamen First Hospital   (China)

Author keywords

CELLCYCLE; CHEMBIO

Indexed keywords

K 80003; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; PROTEIN P85 ALPHA; RETINOID X RECEPTOR ALPHA; SULINDAC; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DENSITY; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; GENE ACTIVATION; GENE DELETION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 77953283014     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.04.023     Document Type: Article

References (50)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
2. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1 (2001) 181-193
3. Altucci L., Rossin A., Hirsch O., Nebbioso A., Vitoux D., Wilhelm E., Guidez F., De Simone M., Schiavone E.M., Grimwade D., et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res. 65 (2005) 8754-8765
4. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9 (2009) 361-371
5. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5 (2000) 289-298
6. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
7. Cao X., Liu W., Lin F., Li H., Kolluri S.K., Lin B., Han Y.-H., Dawson M.I., and Zhang X.-k. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol. 24 (2004) 9705-9725
8. Dawson M.I., and Zhang X.-K. Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid. Curr. Med. Chem. 9 (2002) 623-637
9. Duggan D.E., Hooke K.F., and Hwang S.S. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. Drug Metab. Dispos. 8 (1980) 241-246
10. Fitzgerald G.A. Coxibs and cardiovascular disease. N. Engl. J. Med. 351 (2004) 1709-1711
11. Fukunaka K., Saito T., Wataba K., Ashihara K., Ito E., and Kudo R. Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle. Mol. Hum. Reprod. 7 (2001) 437-446
12. Ghose R., Zimmerman T.L., Thevananther S., and Karpen S.J. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl. Recept. 2 (2004) 4
13. Grosch S., Maier T.J., Schiffmann S., and Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J. Natl. Cancer Inst. 98 (2006) 736-747
14. Haanen C. Sulindac and its derivatives: A novel class of anticancer agents. Curr. Opin. Investig. Drugs 2 (2001) 677-683
15. Han Y.H., Zhou H., Kim J.H., Yan T.D., Lee K.H., Wu H., Lin F., Lu N., Liu J., Zeng J.Z., and Zhang X.K. A unique cytoplasmic localization of retinoic acid receptor-gamma and its regulations. J. Biol. Chem. 284 (2009) 18503-18514
16. Hendry L., and John S. Regulation of STAT signalling by proteolytic processing. Eur. J. Biochem. 271 (2004) 4613-4620
17. Huang J., Powell W.C., Khodavirdi A.C., Wu J., Makita T., Cardiff R.D., Cohen M.B., Sucov H.M., and Roy-Burman P. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor-alpha allele in the prostate epithelium. Cancer Res. 62 (2002) 4812-4819
18. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., et al. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195
19. Kaneko T., Li L., and Li S.S. The SH3 domain-a family of versatile peptide- and protein-recognition module. Front. Biosci. 13 (2008) 4938-4952
20. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?. Cell 83 (1995) 859-869
21. Katagiri Y., Takeda K., Yu Z.X., Ferrans V.J., Ozato K., and Guroff G. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat. Cell Biol. 2 (2000) 435-440
22. Kolluri S.K., Corr M., James S.Y., Bernasconi M., Lu D., Liu W., Cottam H.B., Leoni L.M., Carson D.A., and Zhang X.K. The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Proc. Natl. Acad. Sci. USA 102 (2005) 2525-2530
23. Kolluri S.K., Zhu X., Zhou X., Lin B., Chen Y., Sun K., Tian X., Town J., Cao X., Lin F., et al. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14 (2008) 285-298
24. Kurumbail R.G., Stevens A.M., Gierse J.K., McDonald J.J., Stegeman R.A., Pak J.Y., Gildehaus D., Miyashiro J.M., Penning T.D., Seibert K., et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384 (1996) 644-648
25. Li H., Kolluri S.K., Gu J., Dawson M.I., Cao X., Hobbs P.D., Lin B., Chen G., Lu J., Lin F., et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289 (2000) 1159-1164
26. Li H., Zhu H., Xu C.J., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 (1998) 491-501
27. Li M., Chiba H., Warot X., Messaddeq N., Gerard C., Chambon P., and Metzger D. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 128 (2001) 675-688
28. Lin B., Kolluri S., Lin F., Liu W., Han Y.H., Cao X., Dawson M.I., Reed J.C., and Zhang X.K. Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3. Cell 116 (2004) 527-540
29. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
30. Matsushima-Nishiwaki R., Shidoji Y., Nishiwaki S., Moriwaki H., and Muto Y. Limited degradation of retinoid X receptor by calpain. Biochem. Biophys. Res. Commun. 225 (1996) 946-951
31. Nagaya T., Murata Y., Yamaguchi S., Nomura Y., Ohmori S., Fujieda M., Katunuma N., Yen P.M., Chin W.W., and Seo H. Intracellular proteolytic cleavage of 9-cis-retinoic acid receptor-alpha by cathepsin L-type protease is a potential mechanism for modulating thyroid hormone action. J. Biol. Chem. 273 (1998) 33166-33173
32. Nechushtan A., Smith C.L., Hsu Y.T., and Youle R.J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 18 (1999) 2330-2341
33. Nomura Y., Nagaya T., Yamaguchi S., Katunuma N., and Seo H. Cleavage of RXRalpha by a lysosomal enzyme, cathepsin L-type protease. Biochem. Biophys. Res. Commun. 254 (1999) 388-394
34. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., and Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 82-85
35. Panka D.J., Mano T., Suhara T., Walsh K., and Mier J.W. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 276 (2001) 6893-6896
36. Picard E., Seguin C., Monhoven N., Rochette-Egly C., Siat J., Borrelly J., Martinet Y., Martinet N., and Vignaud J.M. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J. Natl. Cancer Inst. 91 (1999) 1059-1066
37. Pincheira R., Castro A.F., Ozes O.N., Idumalla P.S., and Donner D.B. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J. Immunol. 181 (2008) 1288-1298
38. Sheng H., Shao J., Kirkland S.C., Isakson P., Coffey R.J., Morrow J., Beauchamp R.D., and DuBois R.N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99 (1997) 2254-2259
39. Takiyama Y., Miyokawa N., Sugawara A., Kato S., Ito K., Sato K., Oikawa K., Kobayashi H., Kimura S., and Tateno M. Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas. J. Clin. Endocrinol. Metab. 89 (2004) 5851-5861
40. Thun M.J., Henley S.J., and Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94 (2002) 252-266
41. Witcher M., Shiu H.Y., Guo Q., and Miller Jr. W.H. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells. Blood 104 (2004) 3335-3342
42. Yamamoto Y., Yin M.J., Lin K.M., and Gaynor R.B. Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem. 274 (1999) 27307-27314
43. Ye Y., Lukinova N., and Fortini M.E. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398 (1999) 525-529
44. Zeisig B.B., Kwok C., Zelent A., Shankaranarayanan P., Gronemeyer H., Dong S., and So C.W. Recruitment of RXR by homotetrameric RARalpha fusion proteins is essential for transformation. Cancer Cell 12 (2007) 36-51
45. Zhang L., Yu J., Park B.H., Kinzler K.W., and Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 290 (2000) 989-992
46. Zhang X.-K., Lehmann J., Hoffmann B., Dawson M.I., Cameron J., Graupner G., Hermann T., Tran P., and Pfahl M. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358 (1992) 587-591
47. Zhang X.K., Hoffmann B., Tran P.B., Graupner G., and Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355 (1992) 441-446
48. Zhong C., Yang S., Huang J., Cohen M.B., and Roy-Burman P. Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. Cancer Biol. Ther. 2 (2003) 179-184
49. Zhu J., Nasr R., Peres L., Riaucoux-Lormiere F., Honore N., Berthier C., Kamashev D., Zhou J., Vitoux D., Lavau C., and de The H. RXR is an essential component of the oncogenic PML/RARA complex in vivo. Cancer Cell 12 (2007) 23-35
50. Zimmerman T.L., Thevananther S., Ghose R., Burns A.R., and Karpen S.J. Nuclear export of retinoid X receptor-alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J. Biol. Chem. 281 (2006) 15434-15440